Page last updated: 2024-10-24

chloroquine and Hyperprolactinemia

chloroquine has been researched along with Hyperprolactinemia in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)

Research Excerpts

ExcerptRelevanceReference
"Hyperprolactinemia is likely not associated with disease activity in SLE."1.29Prolactin in systemic lupus erythematosus. ( Gladman, DD; Gough, JM; Pauzner, R; Urowitz, MB, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pauzner, R1
Urowitz, MB1
Gladman, DD1
Gough, JM1

Other Studies

1 other study available for chloroquine and Hyperprolactinemia

ArticleYear
Prolactin in systemic lupus erythematosus.
    The Journal of rheumatology, 1994, Volume: 21, Issue:11

    Topics: Adult; Aged; Chloroquine; Cohort Studies; Female; Humans; Hyperprolactinemia; Longitudinal Studies;

1994